orludodstat   Click here for help

GtoPdb Ligand ID: 11897

Synonyms: BAY-2402234 | BAY2402234
PDB Ligand
Compound class: Synthetic organic
Comment: Orludodstat (BAY-2402234) is an orally bioavailable dihydroorotate dehydrogenase (DHODH) inhibitor [1]. DHODH is important for de novo pyrimidine synthesis, and is a molecular target for treatment of myeloid malignancies [2-3].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 4
Hydrogen bond donors 2
Rotatable bonds 9
Topological polar surface area 97.86
Molecular weight 520.09
XLogP 4.77
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CCn1c(CO)nn(c1=O)c1cc(O[C@H](C(F)(F)F)C)c(cc1F)C(=O)Nc1c(F)cccc1Cl
Isomeric SMILES CCn1c(nn(c1=O)c1c(cc(c(c1)O[C@@H](C)C(F)(F)F)C(=O)Nc1c(cccc1Cl)F)F)CO
InChI InChI=1S/C21H18ClF5N4O4/c1-3-30-17(9-32)29-31(20(30)34)15-8-16(35-10(2)21(25,26)27)11(7-14(15)24)19(33)28-18-12(22)5-4-6-13(18)23/h4-8,10,32H,3,9H2,1-2H3,(H,28,33)/t10-/m0/s1
InChI Key KNVJMHHAXCPZHF-JTQLQIEISA-N
References
1. Christian S, Merz C, Evans L, Gradl S, Seidel H, Friberg A, Eheim A, Lejeune P, Brzezinka K, Zimmermann K et al.. (2019)
The novel dihydroorotate dehydrogenase (DHODH) inhibitor BAY 2402234 triggers differentiation and is effective in the treatment of myeloid malignancies.
Leukemia, 33 (10): 2403-2415. [PMID:30940908]
2. Sykes DB. (2018)
The emergence of dihydroorotate dehydrogenase (DHODH) as a therapeutic target in acute myeloid leukemia.
Expert Opin Ther Targets, 22 (11): 893-898. [PMID:30318938]
3. Wu D, Wang W, Chen W, Lian F, Lang L, Huang Y, Xu Y, Zhang N, Chen Y, Liu M et al.. (2018)
Pharmacological inhibition of dihydroorotate dehydrogenase induces apoptosis and differentiation in acute myeloid leukemia cells.
Haematologica, 103 (9): 1472-1483. [PMID:29880605]